Ligand validation:7U3D

C2E: 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one)

C2E is a Ligand Of Interest in 7U3D designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7U3D_C2E_F_801	84%	2%	0.11	0.973	5.16	1.71	31	14	0	0	100%	1
7U3D_C2E_C_801	83%	3%	0.109	0.968	5.1	1.51	33	11	0	0	100%	1
7U3D_C2E_B_801	80%	2%	0.118	0.968	5.2	1.59	31	13	1	0	100%	1
7U3D_C2E_A_801	75%	2%	0.122	0.957	5.14	1.62	30	11	0	0	100%	1
7U3B_C2E_H_803	67%	38%	0.148	0.959	1.23	1.26	6	5	1	0	100%	1
7U3A_C2E_A_801	50%	2%	0.179	0.929	5.41	1.65	33	15	4	0	100%	1
4RT1_C2E_B_201	99%	19%	0.054	0.982	2.38	1.24	11	7	0	0	100%	1
4URG_C2E_A_1241	97%	18%	0.065	0.983	2.24	1.49	10	10	0	0	100%	1
2RDE_C2E_B_301	97%	46%	0.067	0.983	0.93	1.18	2	6	1	0	100%	1
4RT0_C2E_A_202	97%	15%	0.064	0.978	2.23	1.74	11	13	0	0	100%	1
7B0E_C2E_A_401	96%	40%	0.072	0.984	1.2	1.21	3	4	0	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.